These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1866906)

  • 1. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

  • 2. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].
    De Martiis M; Fontana M; Assogna G; D'Ottavi R; D'Ottavi O
    Clin Ter; 1980 Aug; 94(3):283-315. PubMed ID: 7004762
    [No Abstract]   [Full Text] [Related]  

  • 3. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 4. Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat.
    Valenzuela A; Aspillaga M; Vial S; Guerra R
    Planta Med; 1989 Oct; 55(5):420-2. PubMed ID: 2813578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Silymarin"--an extract from the milk thistle (Silybum marianum)--is it a drug or nutritional supplement?].
    Simánek V; Walterová D; Vicar J; Urbaníková J; Kren V; Modrianský M; Skottová N; Ulrichová J
    Ceska Slov Farm; 2001 Mar; 50(2):66-9. PubMed ID: 11288592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milk thistle (Silybum marianum) for the therapy of liver disease.
    Flora K; Hahn M; Rosen H; Benner K
    Am J Gastroenterol; 1998 Feb; 93(2):139-43. PubMed ID: 9468229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
    Kidd P; Head K
    Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Constituents of Silybum marianum and their therapeutic use].
    Morelli I
    Boll Chim Farm; 1978 May; 117(5):258-67. PubMed ID: 743375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of 23 elements in lady's thistle (Silybum marianum L. Gaertner)].
    Szentmihályi K; Kéry A; Lakatos B; Sándor Z; Petri G
    Acta Pharm Hung; 1998 May; 68(3):157-62. PubMed ID: 9703702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of plants used in the treatment of liver disease: part 1.
    Luper S
    Altern Med Rev; 1998 Dec; 3(6):410-21. PubMed ID: 9855566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
    Pradhan SC; Girish C
    Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Liverubin™ on hepatic biochemical profile in patients of alcoholic liver disease: a retrospective study.
    Nanda V; Gupta V; Sharma SN; Pasricha A; Karmakar AK; Patel A; Bhatt VM; Kantroo BL; Kumar B; Paul NK; Attam R
    Minerva Med; 2014 Dec; 105(6 Suppl 2):1-8. PubMed ID: 26076375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological responses to a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: I induction of transforming growth factor beta1 and c-myc in liver with marginal effects on other genes.
    He Q; Osuchowski MF; Johnson VJ; Sharma RP
    Planta Med; 2002 Aug; 68(8):676-9. PubMed ID: 12221586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of silybin from Silybum marianum (L.) Gaertn. on in vitro phosphatidyl choline biosynthesis in rat livers.
    Schriewer H; Weinhold F
    Arzneimittelforschung; 1979; 29(5):791-2. PubMed ID: 582978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
    Koch HP; Bachner J; Löffler E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The correction with hepatic protectors of structural metabolic disorders in the liver in D-galactosamine poisoning].
    Saratikov AS; Vengerovskiĭ AI; Sedykh IM
    Farmakol Toksikol; 1990; 53(2):38-40. PubMed ID: 2369952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of legalon and essentiale in a tetracycline-induced liver lesion].
    Skakun NP; Stepanova NIu
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):781-4. PubMed ID: 3789688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milk thistle: Silybum marianum.
    Pepping J
    Am J Health Syst Pharm; 1999 Jun; 56(12):1195-7. PubMed ID: 10484652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.